Nasdaq 100 Stocks Performance Guide: Regeneron Pharmaceuticals Inc (REGN)
REGN has no dividends
Table and Chart of REGN Performance
See what a $1,000 investment in REGN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| REGN Returns | |
|---|---|
| Start Date | Nov-29-2013 |
| Start Price | $293.86 |
| End Date | Nov-29-2023 |
| End Price | $808.59 |
| # Prices | 121 |
| Min Date | Dec-31-2013 |
| Min Price | $275.24 |
| Max Date | Aug-31-2023 |
| Max Price | $826.49 |
| Total Return | 175.16% |
| Annualized Return | 10.56% |
| Current Value of $1,000 Purchase | $2,752 |
| Number Returns | 7,260 |
| Average Return | 36.68% |
| Number Profitable Returns | 5,459 |
| Percent Profitable Returns | 75.19% |
| Number Unprofitable Returns | 1,801 |
| Percent Unprofitable Returns | 24.81% |
| Profitable to Unprofitable Returns Ratio | 3.03 |
| REGN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $87,281,803,000 | Price to Sales | 6.66 |
| Earnings per Share | $35.0900 |
| PE Ratio | 22.83 |
| PE to Growth Ratio | 1.725 |
| Price to Book | 3.505 |
| PRICE DATA | |
| 52 Week High | $853.97 |
| 52 Week Low | $668 |
| Analyst Target Price | $920.09 |
| 50-Day Moving Average | $814.01 |
| 200-Day Moving Average | $783.52 |
| FINANCIAL DATA | |
| Revenue per Share | $122.63 |
| Revenue | $13,097,300,000 |
| Profit Margin | 30.5% |
| Return on Equity | 0.172% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
REGN Compare Returns with S&P 500
REGN Trendline Chart